nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Betamethasone—multiple sclerosis	0.236	0.324	CbGbCtD
Nimodipine—NR3C2—Prednisolone—multiple sclerosis	0.233	0.32	CbGbCtD
Nimodipine—NR3C2—Dexamethasone—multiple sclerosis	0.137	0.189	CbGbCtD
Nimodipine—CYP3A4—Fingolimod—multiple sclerosis	0.0259	0.0356	CbGbCtD
Nimodipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0167	0.023	CbGbCtD
Nimodipine—CYP3A5—Dexamethasone—multiple sclerosis	0.0162	0.0223	CbGbCtD
Nimodipine—CYP3A4—Triamcinolone—multiple sclerosis	0.0127	0.0174	CbGbCtD
Nimodipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0122	0.0168	CbGbCtD
Nimodipine—CYP3A4—Betamethasone—multiple sclerosis	0.0109	0.0149	CbGbCtD
Nimodipine—CYP3A4—Prednisolone—multiple sclerosis	0.0107	0.0147	CbGbCtD
Nimodipine—CYP3A4—Prednisone—multiple sclerosis	0.0101	0.0139	CbGbCtD
Nimodipine—CYP3A4—Dexamethasone—multiple sclerosis	0.00632	0.00868	CbGbCtD
Nimodipine—CACNA1F—retina—multiple sclerosis	0.00583	0.0812	CbGeAlD
Nimodipine—CACNB4—medulla oblongata—multiple sclerosis	0.00277	0.0386	CbGeAlD
Nimodipine—CACNB4—midbrain—multiple sclerosis	0.00253	0.0353	CbGeAlD
Nimodipine—CACNB4—spinal cord—multiple sclerosis	0.00247	0.0344	CbGeAlD
Nimodipine—CACNB1—medulla oblongata—multiple sclerosis	0.00221	0.0308	CbGeAlD
Nimodipine—CACNB3—medulla oblongata—multiple sclerosis	0.00212	0.0296	CbGeAlD
Nimodipine—CACNB4—nervous system—multiple sclerosis	0.00208	0.029	CbGeAlD
Nimodipine—CACNB1—midbrain—multiple sclerosis	0.00202	0.0282	CbGeAlD
Nimodipine—CACNB4—central nervous system—multiple sclerosis	0.00201	0.0279	CbGeAlD
Nimodipine—CACNB1—spinal cord—multiple sclerosis	0.00197	0.0275	CbGeAlD
Nimodipine—CACNB2—retina—multiple sclerosis	0.00197	0.0275	CbGeAlD
Nimodipine—CACNB4—cerebellum—multiple sclerosis	0.00196	0.0273	CbGeAlD
Nimodipine—CACNB3—midbrain—multiple sclerosis	0.00194	0.027	CbGeAlD
Nimodipine—Liver function test abnormal—Fingolimod—multiple sclerosis	0.00188	0.0178	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Fingolimod—multiple sclerosis	0.00179	0.017	CcSEcCtD
Nimodipine—Platelet count decreased—Mitoxantrone—multiple sclerosis	0.00175	0.0167	CcSEcCtD
Nimodipine—CACNB1—nervous system—multiple sclerosis	0.00166	0.0232	CbGeAlD
Nimodipine—CACNB1—central nervous system—multiple sclerosis	0.0016	0.0223	CbGeAlD
Nimodipine—CACNB3—nervous system—multiple sclerosis	0.0016	0.0222	CbGeAlD
Nimodipine—CACNB4—brain—multiple sclerosis	0.00159	0.0222	CbGeAlD
Nimodipine—AHR—medulla oblongata—multiple sclerosis	0.00157	0.0219	CbGeAlD
Nimodipine—CACNB1—cerebellum—multiple sclerosis	0.00157	0.0218	CbGeAlD
Nimodipine—Depression—Fingolimod—multiple sclerosis	0.00156	0.0148	CcSEcCtD
Nimodipine—Wheezing—Cladribine—multiple sclerosis	0.00154	0.0146	CcSEcCtD
Nimodipine—CACNB3—central nervous system—multiple sclerosis	0.00154	0.0214	CbGeAlD
Nimodipine—NR3C2—brainstem—multiple sclerosis	0.0015	0.0209	CbGeAlD
Nimodipine—CACNB3—cerebellum—multiple sclerosis	0.0015	0.0209	CbGeAlD
Nimodipine—NR3C2—retina—multiple sclerosis	0.00145	0.0202	CbGeAlD
Nimodipine—AHR—midbrain—multiple sclerosis	0.00144	0.02	CbGeAlD
Nimodipine—Bradycardia—Fingolimod—multiple sclerosis	0.00143	0.0136	CcSEcCtD
Nimodipine—AHR—spinal cord—multiple sclerosis	0.0014	0.0195	CbGeAlD
Nimodipine—Phlebitis—Cladribine—multiple sclerosis	0.00134	0.0127	CcSEcCtD
Nimodipine—Cardiac disorder—Fingolimod—multiple sclerosis	0.0013	0.0124	CcSEcCtD
Nimodipine—Angiopathy—Fingolimod—multiple sclerosis	0.00128	0.0121	CcSEcCtD
Nimodipine—CACNB1—brain—multiple sclerosis	0.00127	0.0177	CbGeAlD
Nimodipine—CACNB3—brain—multiple sclerosis	0.00122	0.017	CbGeAlD
Nimodipine—AHR—cerebellum—multiple sclerosis	0.00111	0.0155	CbGeAlD
Nimodipine—Palpitations—Fingolimod—multiple sclerosis	0.00108	0.0103	CcSEcCtD
Nimodipine—CACNB2—nervous system—multiple sclerosis	0.00107	0.0149	CbGeAlD
Nimodipine—Hypertension—Fingolimod—multiple sclerosis	0.00106	0.01	CcSEcCtD
Nimodipine—NR3C2—medulla oblongata—multiple sclerosis	0.00105	0.0146	CbGeAlD
Nimodipine—CACNB2—central nervous system—multiple sclerosis	0.00103	0.0144	CbGeAlD
Nimodipine—Acne—Prednisolone—multiple sclerosis	0.00102	0.00966	CcSEcCtD
Nimodipine—CACNB2—cerebellum—multiple sclerosis	0.00101	0.014	CbGeAlD
Nimodipine—Nervous system disorder—Fingolimod—multiple sclerosis	0.000979	0.0093	CcSEcCtD
Nimodipine—Sweating increased—Cladribine—multiple sclerosis	0.00097	0.00921	CcSEcCtD
Nimodipine—NR3C2—midbrain—multiple sclerosis	0.000958	0.0133	CbGeAlD
Nimodipine—CACNA1D—nervous system—multiple sclerosis	0.000937	0.013	CbGeAlD
Nimodipine—Acne—Triamcinolone—multiple sclerosis	0.000935	0.00888	CcSEcCtD
Nimodipine—NR3C2—spinal cord—multiple sclerosis	0.000934	0.013	CbGeAlD
Nimodipine—Hypotension—Fingolimod—multiple sclerosis	0.000933	0.00887	CcSEcCtD
Nimodipine—Acne—Methylprednisolone—multiple sclerosis	0.000933	0.00886	CcSEcCtD
Nimodipine—AHR—brain—multiple sclerosis	0.000904	0.0126	CbGeAlD
Nimodipine—CACNA1D—central nervous system—multiple sclerosis	0.000902	0.0126	CbGeAlD
Nimodipine—Dyspnoea—Fingolimod—multiple sclerosis	0.00089	0.00846	CcSEcCtD
Nimodipine—CACNA1D—cerebellum—multiple sclerosis	0.000882	0.0123	CbGeAlD
Nimodipine—Phlebitis—Mitoxantrone—multiple sclerosis	0.000879	0.00835	CcSEcCtD
Nimodipine—CACNA1C—nervous system—multiple sclerosis	0.000865	0.012	CbGeAlD
Nimodipine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000862	0.00819	CcSEcCtD
Nimodipine—Deep vein thrombosis—Methotrexate—multiple sclerosis	0.000854	0.00812	CcSEcCtD
Nimodipine—Acne—Dexamethasone—multiple sclerosis	0.000848	0.00806	CcSEcCtD
Nimodipine—Acne—Betamethasone—multiple sclerosis	0.000848	0.00806	CcSEcCtD
Nimodipine—Hepatobiliary disease—Cladribine—multiple sclerosis	0.000839	0.00798	CcSEcCtD
Nimodipine—Cardiac failure congestive—Mitoxantrone—multiple sclerosis	0.000835	0.00793	CcSEcCtD
Nimodipine—CACNA1C—central nervous system—multiple sclerosis	0.000833	0.0116	CbGeAlD
Nimodipine—CACNB2—brain—multiple sclerosis	0.000819	0.0114	CbGeAlD
Nimodipine—CACNA1C—cerebellum—multiple sclerosis	0.000814	0.0113	CbGeAlD
Nimodipine—Fluid retention—Prednisolone—multiple sclerosis	0.000812	0.00772	CcSEcCtD
Nimodipine—NR3C2—nervous system—multiple sclerosis	0.000787	0.011	CbGeAlD
Nimodipine—Wheezing—Triamcinolone—multiple sclerosis	0.000764	0.00726	CcSEcCtD
Nimodipine—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00076	0.00722	CcSEcCtD
Nimodipine—NR3C2—central nervous system—multiple sclerosis	0.000758	0.0106	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.000757	0.00719	CcSEcCtD
Nimodipine—Fluid retention—Triamcinolone—multiple sclerosis	0.000747	0.0071	CcSEcCtD
Nimodipine—Fluid retention—Methylprednisolone—multiple sclerosis	0.000745	0.00708	CcSEcCtD
Nimodipine—NR3C2—cerebellum—multiple sclerosis	0.000741	0.0103	CbGeAlD
Nimodipine—Cardiac disorder—Cladribine—multiple sclerosis	0.000739	0.00703	CcSEcCtD
Nimodipine—Acne—Prednisone—multiple sclerosis	0.000739	0.00702	CcSEcCtD
Nimodipine—Angiopathy—Cladribine—multiple sclerosis	0.000723	0.00687	CcSEcCtD
Nimodipine—Immune system disorder—Cladribine—multiple sclerosis	0.00072	0.00684	CcSEcCtD
Nimodipine—CACNA1D—brain—multiple sclerosis	0.000716	0.00997	CbGeAlD
Nimodipine—Pruritus—Fingolimod—multiple sclerosis	0.000706	0.00671	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisolone—multiple sclerosis	0.000685	0.00651	CcSEcCtD
Nimodipine—Diarrhoea—Fingolimod—multiple sclerosis	0.000683	0.00649	CcSEcCtD
Nimodipine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.000682	0.00648	CcSEcCtD
Nimodipine—Fluid retention—Dexamethasone—multiple sclerosis	0.000678	0.00644	CcSEcCtD
Nimodipine—Fluid retention—Betamethasone—multiple sclerosis	0.000678	0.00644	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000668	0.00634	CcSEcCtD
Nimodipine—CACNA1C—brain—multiple sclerosis	0.000661	0.0092	CbGeAlD
Nimodipine—Dizziness—Fingolimod—multiple sclerosis	0.00066	0.00627	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.000655	0.00623	CcSEcCtD
Nimodipine—Anaemia—Cladribine—multiple sclerosis	0.000641	0.00609	CcSEcCtD
Nimodipine—Sweating increased—Mitoxantrone—multiple sclerosis	0.000637	0.00606	CcSEcCtD
Nimodipine—Cardiac failure congestive—Triamcinolone—multiple sclerosis	0.00063	0.00598	CcSEcCtD
Nimodipine—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	0.000628	0.00597	CcSEcCtD
Nimodipine—Headache—Fingolimod—multiple sclerosis	0.000626	0.00594	CcSEcCtD
Nimodipine—NR3C2—brain—multiple sclerosis	0.000602	0.00838	CbGeAlD
Nimodipine—Myalgia—Cladribine—multiple sclerosis	0.00059	0.00561	CcSEcCtD
Nimodipine—Fluid retention—Prednisone—multiple sclerosis	0.00059	0.00561	CcSEcCtD
Nimodipine—Immune system disorder—Azathioprine—multiple sclerosis	0.000585	0.00556	CcSEcCtD
Nimodipine—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000571	0.00543	CcSEcCtD
Nimodipine—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000571	0.00543	CcSEcCtD
Nimodipine—Jaundice—Mitoxantrone—multiple sclerosis	0.000569	0.0054	CcSEcCtD
Nimodipine—Oedema—Cladribine—multiple sclerosis	0.000566	0.00538	CcSEcCtD
Nimodipine—Nervous system disorder—Cladribine—multiple sclerosis	0.000555	0.00527	CcSEcCtD
Nimodipine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000554	0.00527	CcSEcCtD
Nimodipine—Tachycardia—Cladribine—multiple sclerosis	0.000552	0.00525	CcSEcCtD
Nimodipine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000547	0.0052	CcSEcCtD
Nimodipine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000533	0.00507	CcSEcCtD
Nimodipine—Hypotension—Cladribine—multiple sclerosis	0.000529	0.00503	CcSEcCtD
Nimodipine—Hepatitis—Mitoxantrone—multiple sclerosis	0.000524	0.00498	CcSEcCtD
Nimodipine—Sweating increased—Prednisolone—multiple sclerosis	0.000523	0.00497	CcSEcCtD
Nimodipine—Anaemia—Azathioprine—multiple sclerosis	0.000521	0.00495	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000516	0.0049	CcSEcCtD
Nimodipine—Dyspnoea—Cladribine—multiple sclerosis	0.000505	0.0048	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000503	0.00478	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000498	0.00473	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000489	0.00464	CcSEcCtD
Nimodipine—Sweating increased—Triamcinolone—multiple sclerosis	0.000481	0.00457	CcSEcCtD
Nimodipine—Myalgia—Azathioprine—multiple sclerosis	0.00048	0.00456	CcSEcCtD
Nimodipine—Sweating increased—Methylprednisolone—multiple sclerosis	0.00048	0.00456	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000451	0.00429	CcSEcCtD
Nimodipine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000451	0.00428	CcSEcCtD
Nimodipine—Bradycardia—Prednisolone—multiple sclerosis	0.000437	0.00416	CcSEcCtD
Nimodipine—Sweating increased—Dexamethasone—multiple sclerosis	0.000436	0.00415	CcSEcCtD
Nimodipine—Sweating increased—Betamethasone—multiple sclerosis	0.000436	0.00415	CcSEcCtD
Nimodipine—Hypotension—Azathioprine—multiple sclerosis	0.00043	0.00409	CcSEcCtD
Nimodipine—Anaemia—Mitoxantrone—multiple sclerosis	0.000421	0.004	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000419	0.00398	CcSEcCtD
Nimodipine—Hypersensitivity—Cladribine—multiple sclerosis	0.000417	0.00396	CcSEcCtD
Nimodipine—Bradycardia—Triamcinolone—multiple sclerosis	0.000402	0.00382	CcSEcCtD
Nimodipine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000401	0.00381	CcSEcCtD
Nimodipine—Pruritus—Cladribine—multiple sclerosis	0.0004	0.00381	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000398	0.00378	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000397	0.00378	CcSEcCtD
Nimodipine—Hypertension—Mitoxantrone—multiple sclerosis	0.000394	0.00374	CcSEcCtD
Nimodipine—Myalgia—Mitoxantrone—multiple sclerosis	0.000388	0.00369	CcSEcCtD
Nimodipine—Diarrhoea—Cladribine—multiple sclerosis	0.000387	0.00368	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—multiple sclerosis	0.00038	0.00361	CcSEcCtD
Nimodipine—Dizziness—Cladribine—multiple sclerosis	0.000374	0.00356	CcSEcCtD
Nimodipine—Oedema—Mitoxantrone—multiple sclerosis	0.000372	0.00354	CcSEcCtD
Nimodipine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000366	0.00348	CcSEcCtD
Nimodipine—Bradycardia—Dexamethasone—multiple sclerosis	0.000365	0.00347	CcSEcCtD
Nimodipine—Bradycardia—Betamethasone—multiple sclerosis	0.000365	0.00347	CcSEcCtD
Nimodipine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000364	0.00346	CcSEcCtD
Nimodipine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000363	0.00345	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00036	0.0038	CbGpPWpGaD
Nimodipine—Vomiting—Cladribine—multiple sclerosis	0.00036	0.00342	CcSEcCtD
Nimodipine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00036	0.00342	CcSEcCtD
Nimodipine—Angiopathy—Methylprednisolone—multiple sclerosis	0.000358	0.0034	CcSEcCtD
Nimodipine—Rash—Cladribine—multiple sclerosis	0.000357	0.00339	CcSEcCtD
Nimodipine—Dermatitis—Cladribine—multiple sclerosis	0.000357	0.00339	CcSEcCtD
Nimodipine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000356	0.00338	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—BCHE—multiple sclerosis	0.000355	0.00374	CbGpPWpGaD
Nimodipine—Headache—Cladribine—multiple sclerosis	0.000355	0.00337	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000348	0.00331	CcSEcCtD
Nimodipine—Hypotension—Mitoxantrone—multiple sclerosis	0.000348	0.0033	CcSEcCtD
Nimodipine—Depression—Prednisone—multiple sclerosis	0.000347	0.0033	CcSEcCtD
Nimodipine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000339	0.00322	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000339	0.00322	CcSEcCtD
Nimodipine—Nausea—Cladribine—multiple sclerosis	0.000336	0.00319	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—APOE—multiple sclerosis	0.000334	0.00352	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—PRNP—multiple sclerosis	0.000332	0.0035	CbGpPWpGaD
Nimodipine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000332	0.00315	CcSEcCtD
Nimodipine—Angiopathy—Dexamethasone—multiple sclerosis	0.000325	0.00309	CcSEcCtD
Nimodipine—Angiopathy—Betamethasone—multiple sclerosis	0.000325	0.00309	CcSEcCtD
Nimodipine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000325	0.00343	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—PRNP—multiple sclerosis	0.000323	0.00341	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—PTPRC—multiple sclerosis	0.000323	0.00341	CbGpPWpGaD
Nimodipine—Hypertension—Prednisolone—multiple sclerosis	0.000323	0.00307	CcSEcCtD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000321	0.00339	CbGpPWpGaD
Nimodipine—CYP3A4—nervous system—multiple sclerosis	0.000319	0.00445	CbGeAlD
Nimodipine—Bradycardia—Prednisone—multiple sclerosis	0.000318	0.00302	CcSEcCtD
Nimodipine—Diarrhoea—Azathioprine—multiple sclerosis	0.000315	0.00299	CcSEcCtD
Nimodipine—CYP3A4—central nervous system—multiple sclerosis	0.000308	0.00428	CbGeAlD
Nimodipine—Oedema—Prednisolone—multiple sclerosis	0.000305	0.0029	CcSEcCtD
Nimodipine—Dizziness—Azathioprine—multiple sclerosis	0.000304	0.00289	CcSEcCtD
Nimodipine—Tachycardia—Prednisolone—multiple sclerosis	0.000298	0.00283	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—FAS—multiple sclerosis	0.000297	0.00314	CbGpPWpGaD
Nimodipine—Hypertension—Triamcinolone—multiple sclerosis	0.000297	0.00282	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—PRNP—multiple sclerosis	0.000296	0.00313	CbGpPWpGaD
Nimodipine—Hypertension—Methylprednisolone—multiple sclerosis	0.000296	0.00282	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—FAS—multiple sclerosis	0.000295	0.00311	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000295	0.0028	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—ZNF746—multiple sclerosis	0.000294	0.0031	CbGpPWpGaD
Nimodipine—Myalgia—Triamcinolone—multiple sclerosis	0.000293	0.00278	CcSEcCtD
Nimodipine—Vomiting—Azathioprine—multiple sclerosis	0.000293	0.00278	CcSEcCtD
Nimodipine—Myalgia—Methylprednisolone—multiple sclerosis	0.000292	0.00278	CcSEcCtD
Nimodipine—Rash—Azathioprine—multiple sclerosis	0.00029	0.00276	CcSEcCtD
Nimodipine—Dermatitis—Azathioprine—multiple sclerosis	0.00029	0.00275	CcSEcCtD
Nimodipine—Depression—Methotrexate—multiple sclerosis	0.00029	0.00275	CcSEcCtD
Nimodipine—Flushing—Prednisone—multiple sclerosis	0.00029	0.00275	CcSEcCtD
Nimodipine—Headache—Azathioprine—multiple sclerosis	0.000288	0.00274	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000287	0.00303	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—BCHE—multiple sclerosis	0.000284	0.00299	CbGpPWpGaD
Nimodipine—Angiopathy—Prednisone—multiple sclerosis	0.000283	0.00269	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—multiple sclerosis	0.000282	0.00268	CcSEcCtD
Nimodipine—Oedema—Triamcinolone—multiple sclerosis	0.000281	0.00267	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—BCHE—multiple sclerosis	0.000276	0.00291	CbGpPWpGaD
Nimodipine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000275	0.00261	CcSEcCtD
Nimodipine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000275	0.00261	CcSEcCtD
Nimodipine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000274	0.0026	CcSEcCtD
Nimodipine—Tachycardia—Triamcinolone—multiple sclerosis	0.000274	0.0026	CcSEcCtD
Nimodipine—Nausea—Azathioprine—multiple sclerosis	0.000273	0.0026	CcSEcCtD
Nimodipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000273	0.0026	CcSEcCtD
Nimodipine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000271	0.00258	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—APOE—multiple sclerosis	0.000271	0.00286	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000271	0.00257	CcSEcCtD
Nimodipine—Hypertension—Dexamethasone—multiple sclerosis	0.000269	0.00256	CcSEcCtD
Nimodipine—Hypertension—Betamethasone—multiple sclerosis	0.000269	0.00256	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—PTBP1—multiple sclerosis	0.000269	0.00284	CbGpPWpGaD
Nimodipine—Myalgia—Dexamethasone—multiple sclerosis	0.000266	0.00252	CcSEcCtD
Nimodipine—Myalgia—Betamethasone—multiple sclerosis	0.000266	0.00252	CcSEcCtD
Nimodipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000262	0.00249	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—multiple sclerosis	0.000261	0.00248	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—FAS—multiple sclerosis	0.000259	0.00274	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—PTPRC—multiple sclerosis	0.000258	0.00273	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000256	0.00271	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000256	0.00243	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000255	0.00242	CcSEcCtD
Nimodipine—Oedema—Betamethasone—multiple sclerosis	0.000255	0.00242	CcSEcCtD
Nimodipine—Oedema—Dexamethasone—multiple sclerosis	0.000255	0.00242	CcSEcCtD
Nimodipine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000255	0.00242	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—PTPRC—multiple sclerosis	0.000251	0.00265	CbGpPWpGaD
Nimodipine—Anaemia—Prednisone—multiple sclerosis	0.000251	0.00239	CcSEcCtD
Nimodipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00025	0.00238	CcSEcCtD
Nimodipine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00025	0.00237	CcSEcCtD
Nimodipine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00025	0.00237	CcSEcCtD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000249	0.00263	CbGpPWpGaD
Nimodipine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000249	0.00237	CcSEcCtD
Nimodipine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000249	0.00237	CcSEcCtD
Nimodipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000249	0.00236	CcSEcCtD
Nimodipine—Tachycardia—Betamethasone—multiple sclerosis	0.000249	0.00236	CcSEcCtD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000246	0.0026	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000246	0.00234	CcSEcCtD
Nimodipine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000246	0.00234	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000246	0.0026	CbGpPWpGaD
Nimodipine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000242	0.0023	CcSEcCtD
Nimodipine—Hypotension—Betamethasone—multiple sclerosis	0.000238	0.00226	CcSEcCtD
Nimodipine—Hypotension—Dexamethasone—multiple sclerosis	0.000238	0.00226	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000238	0.00251	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PRNP—multiple sclerosis	0.000237	0.0025	CbGpPWpGaD
Nimodipine—Angiopathy—Methotrexate—multiple sclerosis	0.000237	0.00225	CcSEcCtD
Nimodipine—CACNA1S—Axon guidance—PRNP—multiple sclerosis	0.000237	0.0025	CbGpPWpGaD
Nimodipine—Vomiting—Mitoxantrone—multiple sclerosis	0.000237	0.00225	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—multiple sclerosis	0.000236	0.00224	CcSEcCtD
Nimodipine—Hypertension—Prednisone—multiple sclerosis	0.000235	0.00223	CcSEcCtD
Nimodipine—Rash—Mitoxantrone—multiple sclerosis	0.000235	0.00223	CcSEcCtD
Nimodipine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000234	0.00223	CcSEcCtD
Nimodipine—Headache—Mitoxantrone—multiple sclerosis	0.000233	0.00221	CcSEcCtD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000233	0.00246	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000233	0.00246	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000233	0.00246	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SRM—multiple sclerosis	0.000233	0.00246	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000232	0.0022	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000232	0.0022	CcSEcCtD
Nimodipine—Myalgia—Prednisone—multiple sclerosis	0.000231	0.0022	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—PRNP—multiple sclerosis	0.000231	0.00243	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—PTPRC—multiple sclerosis	0.000231	0.00243	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00023	0.00243	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00023	0.00243	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000226	0.00239	CbGpPWpGaD
Nimodipine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000225	0.00214	CcSEcCtD
Nimodipine—Oedema—Prednisone—multiple sclerosis	0.000222	0.00211	CcSEcCtD
Nimodipine—Nausea—Mitoxantrone—multiple sclerosis	0.000221	0.0021	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00022	0.00209	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00022	0.00209	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—multiple sclerosis	0.000218	0.00207	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—multiple sclerosis	0.000216	0.00206	CcSEcCtD
Nimodipine—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000216	0.00228	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000216	0.00228	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000214	0.00204	CcSEcCtD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000213	0.00225	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000213	0.00225	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—IL1B—multiple sclerosis	0.000213	0.00224	CbGpPWpGaD
Nimodipine—Anaemia—Methotrexate—multiple sclerosis	0.00021	0.00199	CcSEcCtD
Nimodipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000209	0.00221	CbGpPWpGaD
Nimodipine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000207	0.00197	CcSEcCtD
Nimodipine—AHR—Adipogenesis—STAT3—multiple sclerosis	0.000207	0.00218	CbGpPWpGaD
Nimodipine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000206	0.00196	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000205	0.00216	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—HNRNPA1—multiple sclerosis	0.000204	0.00215	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—U2AF2—multiple sclerosis	0.000204	0.00215	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—PRNP—multiple sclerosis	0.000203	0.00214	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000202	0.00192	CcSEcCtD
Nimodipine—Dizziness—Prednisolone—multiple sclerosis	0.000202	0.00192	CcSEcCtD
Nimodipine—Pruritus—Triamcinolone—multiple sclerosis	0.000199	0.00189	CcSEcCtD
Nimodipine—Pruritus—Methylprednisolone—multiple sclerosis	0.000198	0.00188	CcSEcCtD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000197	0.00208	CbGpPWpGaD
Nimodipine—Myalgia—Methotrexate—multiple sclerosis	0.000193	0.00184	CcSEcCtD
Nimodipine—Rash—Prednisolone—multiple sclerosis	0.000192	0.00183	CcSEcCtD
Nimodipine—Dermatitis—Prednisolone—multiple sclerosis	0.000192	0.00183	CcSEcCtD
Nimodipine—CACNA1D—Axon guidance—PRNP—multiple sclerosis	0.000192	0.00203	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000192	0.00202	CbGpPWpGaD
Nimodipine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000192	0.00182	CcSEcCtD
Nimodipine—AHR—Adipogenesis—TGFB1—multiple sclerosis	0.000192	0.00202	CbGpPWpGaD
Nimodipine—Headache—Prednisolone—multiple sclerosis	0.000191	0.00182	CcSEcCtD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000189	0.00199	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000189	0.00199	CbGpPWpGaD
Nimodipine—Dizziness—Triamcinolone—multiple sclerosis	0.000186	0.00176	CcSEcCtD
Nimodipine—Dizziness—Methylprednisolone—multiple sclerosis	0.000185	0.00176	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—PTPRC—multiple sclerosis	0.000184	0.00194	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—PGR—multiple sclerosis	0.000184	0.00194	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PTPRC—multiple sclerosis	0.000184	0.00194	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000183	0.00193	CbGpPWpGaD
Nimodipine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000182	0.00173	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000181	0.00172	CcSEcCtD
Nimodipine—Nausea—Prednisolone—multiple sclerosis	0.000181	0.00172	CcSEcCtD
Nimodipine—Pruritus—Betamethasone—multiple sclerosis	0.00018	0.00171	CcSEcCtD
Nimodipine—Pruritus—Dexamethasone—multiple sclerosis	0.00018	0.00171	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—PTPRC—multiple sclerosis	0.000179	0.00189	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000179	0.0017	CcSEcCtD
Nimodipine—AHR—Adipogenesis—TNF—multiple sclerosis	0.000179	0.00189	CbGpPWpGaD
Nimodipine—Vomiting—Triamcinolone—multiple sclerosis	0.000178	0.0017	CcSEcCtD
Nimodipine—Vomiting—Methylprednisolone—multiple sclerosis	0.000178	0.00169	CcSEcCtD
Nimodipine—Rash—Triamcinolone—multiple sclerosis	0.000177	0.00168	CcSEcCtD
Nimodipine—Dermatitis—Triamcinolone—multiple sclerosis	0.000177	0.00168	CcSEcCtD
Nimodipine—Rash—Methylprednisolone—multiple sclerosis	0.000177	0.00168	CcSEcCtD
Nimodipine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000176	0.00168	CcSEcCtD
Nimodipine—Headache—Triamcinolone—multiple sclerosis	0.000176	0.00167	CcSEcCtD
Nimodipine—Headache—Methylprednisolone—multiple sclerosis	0.000175	0.00167	CcSEcCtD
Nimodipine—Diarrhoea—Betamethasone—multiple sclerosis	0.000174	0.00166	CcSEcCtD
Nimodipine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000174	0.00166	CcSEcCtD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL1B—multiple sclerosis	0.000174	0.00184	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—BCHE—multiple sclerosis	0.000173	0.00183	CbGpPWpGaD
Nimodipine—Hypotension—Methotrexate—multiple sclerosis	0.000173	0.00165	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—IL1B—multiple sclerosis	0.000173	0.00182	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.00017	0.0018	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000169	0.0016	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—PRNP—multiple sclerosis	0.000169	0.00178	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000169	0.00178	CbGpPWpGaD
Nimodipine—Dizziness—Dexamethasone—multiple sclerosis	0.000168	0.0016	CcSEcCtD
Nimodipine—Dizziness—Betamethasone—multiple sclerosis	0.000168	0.0016	CcSEcCtD
Nimodipine—Nausea—Triamcinolone—multiple sclerosis	0.000167	0.00158	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000167	0.00176	CbGpPWpGaD
Nimodipine—Nausea—Methylprednisolone—multiple sclerosis	0.000166	0.00158	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000165	0.00157	CcSEcCtD
Nimodipine—CACNB3—Metabolism—CYP24A1—multiple sclerosis	0.000164	0.00173	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP27B1—multiple sclerosis	0.000164	0.00173	CbGpPWpGaD
Nimodipine—Hypersensitivity—Prednisone—multiple sclerosis	0.000163	0.00155	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—MAPK1—multiple sclerosis	0.000162	0.00171	CbGpPWpGaD
Nimodipine—Vomiting—Dexamethasone—multiple sclerosis	0.000162	0.00154	CcSEcCtD
Nimodipine—Vomiting—Betamethasone—multiple sclerosis	0.000162	0.00154	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	0.000161	0.0017	CbGpPWpGaD
Nimodipine—Rash—Dexamethasone—multiple sclerosis	0.000161	0.00153	CcSEcCtD
Nimodipine—Rash—Betamethasone—multiple sclerosis	0.000161	0.00153	CcSEcCtD
Nimodipine—Dermatitis—Dexamethasone—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Nimodipine—Dermatitis—Betamethasone—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Nimodipine—Headache—Dexamethasone—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Nimodipine—Headache—Betamethasone—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—PTPRC—multiple sclerosis	0.000158	0.00166	CbGpPWpGaD
Nimodipine—Pruritus—Prednisone—multiple sclerosis	0.000157	0.00149	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000157	0.00165	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—multiple sclerosis	0.000154	0.00163	CbGpPWpGaD
Nimodipine—Diarrhoea—Prednisone—multiple sclerosis	0.000152	0.00144	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	0.000152	0.0016	CbGpPWpGaD
Nimodipine—Nausea—Dexamethasone—multiple sclerosis	0.000151	0.00144	CcSEcCtD
Nimodipine—Nausea—Betamethasone—multiple sclerosis	0.000151	0.00144	CcSEcCtD
Nimodipine—CACNB3—Metabolism—GPC5—multiple sclerosis	0.00015	0.00158	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—PTPRC—multiple sclerosis	0.000149	0.00158	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000148	0.00157	CbGpPWpGaD
Nimodipine—Dizziness—Prednisone—multiple sclerosis	0.000147	0.00139	CcSEcCtD
Nimodipine—CACNB2—Developmental Biology—PRNP—multiple sclerosis	0.000145	0.00153	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—TYK2—multiple sclerosis	0.000145	0.00153	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IL6—multiple sclerosis	0.000144	0.00152	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SRM—multiple sclerosis	0.000142	0.0015	CbGpPWpGaD
Nimodipine—Vomiting—Prednisone—multiple sclerosis	0.000141	0.00134	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.00014	0.00148	CbGpPWpGaD
Nimodipine—Rash—Prednisone—multiple sclerosis	0.00014	0.00133	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—multiple sclerosis	0.00014	0.00133	CcSEcCtD
Nimodipine—Headache—Prednisone—multiple sclerosis	0.000139	0.00132	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—PRNP—multiple sclerosis	0.000137	0.00145	CbGpPWpGaD
Nimodipine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000135	0.00143	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SRM—multiple sclerosis	0.000135	0.00142	CbGpPWpGaD
Nimodipine—Nausea—Prednisone—multiple sclerosis	0.000132	0.00125	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—MAPK1—multiple sclerosis	0.000132	0.00139	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PTPRC—multiple sclerosis	0.000131	0.00139	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	0.000131	0.00139	CbGpPWpGaD
Nimodipine—Pruritus—Methotrexate—multiple sclerosis	0.000131	0.00125	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.00013	0.00138	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	0.000129	0.00136	CbGpPWpGaD
Nimodipine—Diarrhoea—Methotrexate—multiple sclerosis	0.000127	0.00121	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—multiple sclerosis	0.000125	0.00132	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PABPC1—multiple sclerosis	0.000125	0.00132	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—RRM1—multiple sclerosis	0.000124	0.00131	CbGpPWpGaD
Nimodipine—Dizziness—Methotrexate—multiple sclerosis	0.000123	0.00116	CcSEcCtD
Nimodipine—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	0.00012	0.00127	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.00012	0.00127	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00012	0.00127	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SRM—multiple sclerosis	0.000118	0.00125	CbGpPWpGaD
Nimodipine—Vomiting—Methotrexate—multiple sclerosis	0.000118	0.00112	CcSEcCtD
Nimodipine—Rash—Methotrexate—multiple sclerosis	0.000117	0.00111	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—multiple sclerosis	0.000117	0.00111	CcSEcCtD
Nimodipine—Headache—Methotrexate—multiple sclerosis	0.000116	0.0011	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—TYK2—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MMP9—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—RPL5—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PTPRC—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—TYK2—multiple sclerosis	0.000112	0.00119	CbGpPWpGaD
Nimodipine—Nausea—Methotrexate—multiple sclerosis	0.00011	0.00105	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000108	0.00114	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PTPRC—multiple sclerosis	0.000107	0.00112	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000105	0.00111	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—MAPK1—multiple sclerosis	0.000104	0.00109	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TYK2—multiple sclerosis	0.000103	0.00109	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	0.000102	0.00108	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—IL6—multiple sclerosis	0.000102	0.00108	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP27B1—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP24A1—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.9e-05	0.00104	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.9e-05	0.00104	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP27B1—multiple sclerosis	9.49e-05	0.001	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP24A1—multiple sclerosis	9.49e-05	0.001	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	9.37e-05	0.000988	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MAPK1—multiple sclerosis	9.2e-05	0.000971	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPC5—multiple sclerosis	9.17e-05	0.000967	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.14e-05	0.000965	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP9—multiple sclerosis	9.1e-05	0.00096	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PGR—multiple sclerosis	8.87e-05	0.000936	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP9—multiple sclerosis	8.85e-05	0.000934	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPC5—multiple sclerosis	8.68e-05	0.000916	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	8.34e-05	0.00088	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	8.34e-05	0.00088	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—MAPK1—multiple sclerosis	8.29e-05	0.000875	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TYK2—multiple sclerosis	8.25e-05	0.00087	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—TYK2—multiple sclerosis	8.23e-05	0.000869	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP9—multiple sclerosis	8.12e-05	0.000857	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—MAPK1—multiple sclerosis	8.06e-05	0.000851	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TYK2—multiple sclerosis	8.02e-05	0.000846	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPC5—multiple sclerosis	7.63e-05	0.000805	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RRM1—multiple sclerosis	7.6e-05	0.000802	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MAPK1—multiple sclerosis	7.35e-05	0.000776	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—STAT3—multiple sclerosis	7.22e-05	0.000762	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RRM1—multiple sclerosis	7.19e-05	0.000759	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MAPK1—multiple sclerosis	7.15e-05	0.000755	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—BCHE—multiple sclerosis	7.14e-05	0.000754	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—multiple sclerosis	7.07e-05	0.000746	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—TYK2—multiple sclerosis	7.06e-05	0.000745	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TGFB1—multiple sclerosis	6.69e-05	0.000706	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—TYK2—multiple sclerosis	6.68e-05	0.000705	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.61e-05	0.000697	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MAPK1—multiple sclerosis	6.56e-05	0.000693	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—multiple sclerosis	6.49e-05	0.000685	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—multiple sclerosis	6.48e-05	0.000684	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RRM1—multiple sclerosis	6.32e-05	0.000667	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—multiple sclerosis	6.32e-05	0.000667	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—multiple sclerosis	6.25e-05	0.00066	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—VDR—multiple sclerosis	6.2e-05	0.000654	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TYK2—multiple sclerosis	5.88e-05	0.00062	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—TYK2—multiple sclerosis	5.87e-05	0.00062	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—multiple sclerosis	5.77e-05	0.000609	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—multiple sclerosis	5.65e-05	0.000596	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—multiple sclerosis	5.62e-05	0.000593	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—multiple sclerosis	5.56e-05	0.000587	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—multiple sclerosis	5.5e-05	0.00058	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—multiple sclerosis	5.35e-05	0.000565	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—multiple sclerosis	5.26e-05	0.000556	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MAPK1—multiple sclerosis	5.25e-05	0.000554	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.24e-05	0.000553	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MAPK1—multiple sclerosis	5.24e-05	0.000553	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SRM—multiple sclerosis	5.24e-05	0.000553	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—multiple sclerosis	5.21e-05	0.000549	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	5.12e-05	0.00054	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MAPK1—multiple sclerosis	5.11e-05	0.000539	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—MAPK1—multiple sclerosis	5.06e-05	0.000534	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—multiple sclerosis	5.04e-05	0.000532	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TYK2—multiple sclerosis	5.04e-05	0.000532	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—multiple sclerosis	5e-05	0.000527	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—multiple sclerosis	4.86e-05	0.000513	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.86e-05	0.000512	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TYK2—multiple sclerosis	4.77e-05	0.000503	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—multiple sclerosis	4.63e-05	0.000488	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—multiple sclerosis	4.63e-05	0.000488	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK1—multiple sclerosis	4.49e-05	0.000474	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—BCHE—multiple sclerosis	4.36e-05	0.00046	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APOE—multiple sclerosis	4.3e-05	0.000453	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK1—multiple sclerosis	4.25e-05	0.000449	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.25e-05	0.000449	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	4.19e-05	0.000442	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—BCHE—multiple sclerosis	4.13e-05	0.000436	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	4.11e-05	0.000434	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—multiple sclerosis	4.03e-05	0.000426	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—multiple sclerosis	4.03e-05	0.000425	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—multiple sclerosis	3.97e-05	0.000419	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—multiple sclerosis	3.92e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	3.81e-05	0.000402	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	3.76e-05	0.000396	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	3.74e-05	0.000395	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	3.74e-05	0.000395	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.69e-05	0.00039	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.69e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POMC—multiple sclerosis	3.69e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—BCHE—multiple sclerosis	3.63e-05	0.000383	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—multiple sclerosis	3.56e-05	0.000376	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—multiple sclerosis	3.53e-05	0.000372	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—multiple sclerosis	3.45e-05	0.000364	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.38e-05	0.000356	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—multiple sclerosis	3.37e-05	0.000355	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	3.34e-05	0.000352	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	3.3e-05	0.000348	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—multiple sclerosis	3.27e-05	0.000345	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—multiple sclerosis	3.27e-05	0.000345	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK1—multiple sclerosis	3.21e-05	0.000338	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	3.1e-05	0.000327	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—multiple sclerosis	3.05e-05	0.000322	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	3.04e-05	0.00032	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	2.93e-05	0.00031	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—multiple sclerosis	2.89e-05	0.000305	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—multiple sclerosis	2.87e-05	0.000303	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—multiple sclerosis	2.87e-05	0.000303	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	2.72e-05	0.000287	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	2.67e-05	0.000282	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOE—multiple sclerosis	2.62e-05	0.000277	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—multiple sclerosis	2.54e-05	0.000268	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOE—multiple sclerosis	2.49e-05	0.000262	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—multiple sclerosis	2.46e-05	0.00026	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—multiple sclerosis	2.46e-05	0.00026	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.44e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—multiple sclerosis	2.33e-05	0.000246	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.26e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POMC—multiple sclerosis	2.25e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOE—multiple sclerosis	2.18e-05	0.00023	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POMC—multiple sclerosis	2.14e-05	0.000225	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—multiple sclerosis	2.06e-05	0.000217	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—multiple sclerosis	2.05e-05	0.000216	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—multiple sclerosis	1.95e-05	0.000205	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POMC—multiple sclerosis	1.88e-05	0.000198	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.72e-05	0.000181	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.72e-05	0.000181	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—multiple sclerosis	1.71e-05	0.000181	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.00017	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.000166	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000137	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOE—multiple sclerosis	9.67e-06	0.000102	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POMC—multiple sclerosis	8.31e-06	8.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—multiple sclerosis	7.57e-06	7.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.47e-06	7.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.49e-06	4.74e-05	CbGpPWpGaD
Nimodipine—Clevidipine—BCHE—multiple sclerosis	3.97e-06	1	CrCbGaD
Nimodipine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.86e-06	4.07e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.52e-06	3.71e-05	CbGpPWpGaD
